Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of Nexvax2 in Subjects With Coeliac Disease
Phase 1
Completed
- Conditions
- Coeliac DiseaseCeliac Disease
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2011-04-07
- Lead Sponsor
- Nexpep Pty Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT00879749
- Locations
- 🇦🇺
Q-Pharm Pty Ltd, Herston, Queensland, Australia
🇦🇺Nucleus Network - Centre for Clinical Studies, Melbourne, Victoria, Australia
News
No news found